In agreement with an earlier study using the LDL receptor–deficient (Ldlr-deficient) animal model with bone marrow transfer (25), our data confirm that TRAM deficiency potently alleviates atherogenesis in atherosclerosis-prone mice accompanied by attenuated inflammation. Here, TICAM2 is linked to atherosclerosis.